Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525-Reference-Cited by-同舟云学术

Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525

Published:2018-01 Issue:1 Volume:100 Page:38-44
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Shi Wenyin,Scannell Bryan Molly,Gilbert Mark R.,Mehta Minesh P.,Blumenthal Deborah T.,Brown Paul D.,Valeinis Egils,Hopkins Kirsten,Souhami Luis,Andrews David W.,Tzuk-Shina Tzahala,Howard Steve P.,Youssef Emad F.,Lessard Nathalie,Dignam James J.,Werner-Wasik Maria

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference22 articles.

1. Recurrent malignant gliomas;Kirkpatrick;Semin Radiat Oncol,2014

2. Mechlorethamine, vincristine, and procarbazine chemotherapy for recurrent high-grade glioma in adults: A phase II study;Coyle;J Clin Oncol,1990

3. Phase II trial with BCNU plus alpha-interferon in patients with recurrent high-grade gliomas;Brandes;Am J Clin Oncol,1997

4. A phase II study of paclitaxel in chemonaïve patients with recurrent high-grade glioma;Postma;Ann Oncol,2000

5. Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme;Groves;J Clin Oncol,2002

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective Randomized Phase 2 Trial of Hypofractionated Stereotactic Radiation Therapy of 25 Gy in 5 Fractions Compared With 35 Gy in 5 Fractions in the Reirradiation of Recurrent Glioblastoma;International Journal of Radiation Oncology*Biology*Physics;2024-07

2. Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study;Trials;2024-06-07

3. Targeted Alpha Therapy for Glioblastoma: Review on In Vitro, In Vivo and Clinical Trials;Targeted Oncology;2024-06-05

4. The role of surgical treatment of recurrent glioblastomas;Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery);2024-04-22

5. Novel Clinical Trials and Approaches in the Management of Glioblastoma;Current Oncology Reports;2024-03-28